Manoela Manova
Overview
Explore the profile of Manoela Manova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savova A, Manova M, Tachkov K, Petrova G
Expert Rev Pharmacoecon Outcomes Res
. 2023 Dec;
24(2):189-202.
PMID: 38064353
Introduction: This overview paper aims at summarizing and analyzing the available literature on healthcare system organization and pricing policies of 11 European countries, comparing them to the Bulgarian pharmaceutical system....
2.
Jakab I, Dimitrova M, Houyez F, Bereczky T, Fovenyes M, Maravic Z, et al.
Front Public Health
. 2023 Jul;
11:1176200.
PMID: 37465169
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected...
3.
Zemplenyi A, Tachkov K, Balkanyi L, Nemeth B, Petyko Z, Petrova G, et al.
Front Public Health
. 2023 May;
11:1088121.
PMID: 37181704
Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA)...
4.
Tachkov K, Savova A, Manova M, Petrova G
Expert Rev Pharmacoecon Outcomes Res
. 2023 Apr;
23(6):597-606.
PMID: 37055731
Introduction: Ensuring both financial and physical access to medicines is a challenge for the reimbursement system. How countries are currently tackling this challenge is an issue worth exploring in this...
5.
Malinowski K, Kawalec P, Trabka W, Sowada C, Petrova G, Manova M, et al.
Orphanet J Rare Dis
. 2020 Oct;
15(1):277.
PMID: 33032634
Background: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was...
6.
Mitkova Z, Vasileva M, Savova A, Manova M, Terezova S, Petrova G
Front Public Health
. 2020 Sep;
8:433.
PMID: 32974262
The aim of the current study was to compare pricing methodologies at the manufacturer, wholesale, and retail levels, and to estimate the price differences of AT1-receptor blockers (sartans), Angiotensin-converting enzyme...
7.
Tachkov K, Mitov K, Koleva Y, Mitkova Z, Kamusheva M, Dimitrova M, et al.
PLoS One
. 2020 May;
15(5):e0232815.
PMID: 32392235
Aims: To evaluate the expected life expectancy in patients with diabetes in Bulgaria and to compare it to the expected life expectancy of the non-diabetic population in the country. Methods:...
8.
Russel-Szymczyk M, Valov V, Savova A, Manova M
BMC Endocr Disord
. 2019 Dec;
19(1):132.
PMID: 31796048
Background: This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in...
9.
Tkachova O, Iakovlieva L, Mitkova Z, Manova M, Savova A, Petrova G
BMC Health Serv Res
. 2019 Nov;
19(1):902.
PMID: 31775736
Background: The statins are а developing group of cardiovascular medicines, widely used for dyslipidemia. As a whole statins consumption leads to reduction in cardiovascular events and death, and improves the...
10.
Malinowski K, Kawalec P, Trabka W, Czech M, Petrova G, Manova M, et al.
Front Pharmacol
. 2019 May;
10:487.
PMID: 31139080
Background: Reimbursement policies influence access of patients to orphan drugs in the European countries. Objectives: To provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making...